US Codex
U.S.C.
Browse by date
Notes

§360bbb–0. Expanded access policy required for investigational drugs — Lineage

21 U.S.C. § 360bbb–0

How 21 U.S.C. § 360bbb–0 came to say what it says — from its enactment, through every amendment and release point, to the regulations that draw authority from it.

How this provision came to be

  1. Aug 18, 2017 Amendment Pub. L. 115–52 — FDA Reauthorization Act of 2017 See what changed
  2. Dec 13, 2016 Enacted Pub. L. 114–255 — 21st Century Cures Act
  3. Dec 13, 2016 Bill stage H.R. 34 (Enrolled Bill) Enrolled Bill
  4. Nov 30, 2016 Bill stage H.R. 34 (Engrossed Amendment House) Engrossed Amendment House
  5. Oct 6, 2015 Bill stage H.R. 34 (Engrossed Amendment Senate) Engrossed Amendment Senate
  6. Jan 8, 2015 Bill stage H.R. 34 (Reported in Senate) Reported in Senate
  7. Jan 8, 2015 Bill stage H.R. 34 (Referred in Senate) Referred in Senate
  8. Jan 7, 2015 Bill stage H.R. 34 (Engrossed in House) Engrossed in House
  9. Jan 6, 2015 Bill stage H.R. 34 (Introduced in House) Introduced in House

Release history

3 of 402 release points changed the text.

  1. reading now Public Law 119-102 Text changed See what changed
  2. 271 release points — no change to the text
  3. 21 release points — no change to the text
  4. Public Law 114-321 Text changed
  5. 107 release points — not in the Code